| Literature DB >> 30575695 |
Cecilia J Sorensen1, Jaime Butler-Dawson, Miranda Dally, Lyndsay Krisher, Benjamin R Griffin, Richard J Johnson, Jay Lemery, Claudia Asensio, Liliana Tenney, Lee S Newman.
Abstract
OBJECTIVE: Identify early biomarkers and mechanisms of acute kidney injury in workers at risk of developing chronic kidney disease of unknown origin (CKDu).Entities:
Year: 2019 PMID: 30575695 PMCID: PMC6416034 DOI: 10.1097/JOM.0000000000001529
Source DB: PubMed Journal: J Occup Environ Med ISSN: 1076-2752 Impact factor: 2.162
FIGURE 1Mechanisms by which recurrent exposure to high ambient temperature and high physical workloads, in synergy with other exposures and risk factors, may lead to CKDu. CKDu, chronic kidney disease of unknown origin.
Pre-Harvest Demographic and Clinical Characteristics of the Study Population
| Baseline Characteristics | All Participants | Cane Cutters | Production Workers | |
| Demographic, mean (SD) | ||||
| Age, yrs | 30.1 (9.1) | 29.05 (8.1) | 34.0 (11.3) | <0.05 |
| Home residence, | ||||
| Local | 63 (60%) | 41 (49%) | 22 (100%) | <0.01 |
| Highland | 42 (40%) | 42 (51%) | 0 (0%) | |
| Number of seasons worked | 7.1 (5.2) | 7.2 (5.0) | 6.7 (6.1) | 0.21 |
| Clinical, mean (SD) | ||||
| Body mass index | 23.6 (2.8) | 23.2 (2.5) | 25.2 (3.1) | <0.01 |
| Pre-harvest serum creatinine, mg/dL | 0.9 (0.2) | 0.9 (0.2) | 0.9 (0.1) | 0.5 |
| Pre-harvest eGFR, mL/min/1.73 m2 | 111.1 (15.6) | 111.5 (15.8) | 109.7 (14.9) | 0.6 |
| Pre-harvest eGFR <90, | 13 (12.4%) | 10 (12.1%) | 3 (13.6%) | 1.0 |
| Pre-harvest eGFR >90, | 92 (87.6%) | 73 (87.9%) | 19 (86.4%) | |
| HbA1c | 5.66 (0.29) | 5.65 (0.28) | 5.68 (0.32) | 0.75 |
| HbA1c (>6.5) | 0 (0.00%) | 0 (0.00%) | 0 (0.00%) | – |
| HbA1c (5.7–6.4), | 53 (50%) | 40 (48%) | 13 (59%) | 0.36 |
| Hypertension | 4 (4%) | 2 (3%) | 2 (9%) | 0.22 |
Median or mean (SD) are shown for continuous variables, number (n), and percent (%) for demographics and medical conditions.
*HbA1c was measured post-shift in February.
**Stage 1 hypertension as defined as a systolic blood pressure from 130-139 or a diastolic blood pressure from 80-89.
Self-Reported Water and Electrolyte Intake
| Water Intake, L | Electrolyte Solution Intake (500 mL bag) | |||||
| Mean (SD) | Median (Range) | Mean (SD) | Median (Range) | |||
| February | 103 | 13.8 (6.3) | 15 (34.0) | 100 | 5.0 (3.0) | 5.0 (12.0) |
| March | 88 | 13.7 (4.7) | 15 (18.0) | 88 | 5.0 (3.4) | 5.0 (17.0) |
| April | 92 | 12.7 (4.4) | 15 (18.0) | 91 | 5.4 (3.1) | 5.0 (18.0) |
*Each 500 mL bag of electrolyte solution contains 4 g sodium citrate, 4.6 g sodium chloride, 2 g potassium chloride, 34 g carbohydrates, and 26 g sucrose.
FIGURE 2A: Pre-shift urine specific gravity among study participants, averaged across February, March, and April, 2017. B: Post-shift urine specific gravity among study participants, averaged across February, March, and April, 2017.
FIGURE 3Comparison between pre- and post-shift eGFR during 3 study months (left) and cross-shift percent change in eGFR (right). eGFR, estimated glomerular filtration rate.
Heat Exposure, Productivity, Behaviors, and Pre- and Post-Shift Urinary Biomarkers for February, March, and April
| February, Mean (SD) or | March, Mean (SD) or | April, Mean (SD) or | |
| Heat exposure | |||
| Average WBGT | 31.57 (1.21) | 30.67 (1.09) | 31.5 (0.7) |
| Maximum WBGT | 34.94 (1.57) | 34.25 (1.33) | 34.2 (0.7) |
| Productivity | |||
| Cane harvested on study day (tons/worker) | 6.19 (2.25) | 6.59 (2.52) | 5.7 (2.0) |
| Can harvested on previous day (tons/worker) | 6.31 (2.43) | 6.37 (3.46) | 5.9 (1.7) |
| Self-reported behaviors | |||
| Smoked cigarette on study day | 5 (5%) | 5 (6%) | 7 (8%) |
| NSAID use on study day | 12 (12%) | 3 (4%) | 2 (2%) |
Bold values are statistically significant.
*Normal values not established.
Post-Shift Biomarkers of Injury From February, March, and April, 2017
| February | March | April | ||
| Post-Shift Serum Biomarkers | Normal Values | Mean (SD) or | Mean (SD) or | Mean (SD) or |
| Creatine kinase | 174 (IU/L) | 436.7 (241.3) | 339.9 (239.6) | 425.0 (370.0) |
| Lactate | 0.5–1 (mmol/L) | 3.8 (1.4) | 3.34 (1.03) | 3.9 (0.9) |
| Uric acid | 3.4–7.0 (mg/dL) | 6.2 (2.4) | 6.16 (2.19) | 6.4 (1.3) |
| Uric acid >7.0 | 18 (18%) | 18 (23%) | 24 (28%) | |
| Glucose | 70–100 (mg/dL) | 81.8 (13.7) | 85.4 (13.5) | 88.4 (15.6) |
| Blood urea nitrogen (BUN) | 7–20 (mg/dL) | 14.8 (5.7) | 12.9 (4.3) | 13.4 (5.2) |
| Osmolality <280 | 280–295 (mmol/kg) | 51 (51%) | 34 (43%) | 31 (36%) |
| Osmolality >295 | 280–295 (mmol/kg) | 1 (1%) | 1 (1%) | 2 (2%) |
| Potassium | 3.5–5.0 (mmol/L) | 3.5 (0.46) | 3.4 (0.40) | 3.5 (0.40) |
| Sodium | 135–145 (mmol/L) | 134.39 (3.77) | 135.35 (3.29) | 136.00 (3.50) |
| ΔIntracellular volume | (L) | 0.95 (0.66) | 0.78 (0.57) | 0.66 (0.58) |
| ΔExtracellular volume | (L) | −1.00 (1.79) | −0.68 (1.40) | −0.24 (2.33) |
*Normal values not established.
Univariate Analysis Testing Associations Between Risk Factors and Percent Change in eGFR Across the Work Shift
| Effect | Estimate | Standard Error | DF | ||
| Demographics and baseline health | |||||
| Age | |||||
| Harvests worked ( | |||||
| Highland | −1.4 | 2.0 | 81.0 | −0.7 | 0.51 |
| Body mass index, kg/m | −0.3 | 0.4 | 95.0 | −0.9 | 0.40 |
| HgA1c | |||||
| Hypertension (stage 1) | −0.2 | 5.5 | 95.0 | 0.0 | 0.96 |
| Pre-harvest eGFR | |||||
| Pre-Shift eGFR | 0.0 | 0.0 | 175.0 | 0.6 | 0.54 |
| NSAID use | 1.2 | 3.0 | 100 | 0.4 | 0.69 |
| Smoking | −2.7 | 3.5 | 158 | −0.8 | 0.44 |
| Heat exposure | |||||
| Average WBGT | −0.6 | 0.7 | 165 | −0.8 | 0.44 |
| Maximum WBGT | −0.2 | 0.6 | 165 | −0.4 | 0.73 |
| Physical work load | |||||
| Cane harvested | 0.0 | 0.4 | 132.0 | −0.1 | 0.90 |
| Cane harvested (prior day) | −0.5 | 0.4 | 62.0 | −1.2 | 0.22 |
| Pre-shift urine biomarkers | |||||
| Specific gravity | |||||
| NGAL | |||||
| Leukocyte esterase, ≥70+/μL | −2.9 | 2.7 | 84.0 | −1.1 | 0.29 |
| Albumin–creatinine ratio | 0.0 | 0.0 | 168.0 | 0.5 | 0.60 |
| pH = 6.0–6.5 (ref: 7.0–7.5) | |||||
| pH = 5.0 (ref: 7.0–7.5) | −3.2 | 2.5 | 78 | −1.3 | 0.20 |
| Uric acid | |||||
| Sodium/creatinine | |||||
| Magnesium/creatinine | |||||
| Proteinuria >1+ | 4.7 | 12.8 | 173.0 | 0.4 | 0.71 |
| Post-shift urine biomarkers | |||||
| Specific gravity | |||||
| NGAL | |||||
| Leukocyte esterase, ≥70+/μL | |||||
| Albumin–creatinine ratio | 0.0 | 0.0 | 161.0 | −0.9 | 0.36 |
| pH = 6.0–6.5 (ref: 7.0–7.5) | −1.8 | 1.7 | 68 | −1.0 | 0.30 |
| pH = 5.0 (ref: 7.0–7.5) | |||||
| Uric acid | −0.1 | 0.1 | 162.0 | −1.8 | 0.08 |
| Sodium/creatinine | 0.0 | 0.0 | 161.0 | 1.8 | 0.07 |
| Magnesium/creatinine | 23.6 | 14.7 | 162 | 1.6 | 0.11 |
| Proteinuria >1+ | 2.7 | 6.8 | 174 | 0.4 | 0.70 |
| Post-shift serum biomarkers | |||||
| Creatine kinase, continuous | 0.0 | 0.0 | 157.0 | 1.2 | 0.25 |
| Creatine kinase, 174–870 (ref: ≤174) | 4. | 2.6 | 25 | 1.6 | 0.23 |
| Creatine kinase, ≥870 (ref: ≤174) | 5.5 | 4.3 | 25 | 1.3 | 0.21 |
| Lactate | 0.0 | 0.7 | 158.0 | −0.1 | 0.95 |
| Uric acid | |||||
| Hyperuricemia (>7.0) | |||||
| Glucose | 0.0 | 0.1 | 100.0 | −0.3 | 0.76 |
| Blood urea nitrogen | |||||
| Serum osmolality (cont.) | |||||
| Serum osmolality <280 | 3.9 | 1.7 | 40.0 | 2.3 | 0.03 |
| Serum osmolality >295 | |||||
| Potassium | 2.0 | 2.1 | 157.0 | 1.0 | 0.34 |
| Sodium | −0.3 | 0.2 | 158.0 | −1.1 | 0.28 |
| ΔIntracellular volume | 1.9 | 1.4 | 158.0 | 1.3 | 0.18 |
Bold values are statistically significant.
eGFR, estimated glomerular filtration rate; NGAL, neutrophil gelatinase-associated lipocalin; NSAID, non-steroidal anti-inflammatory drug.
*Last study day removed from analysis because WBGT meter only ran for 40 minutes during the work shift.
Multivariable Analysis of Pre-Shift Biomarkers Associated With Percent Change in Cross-Shift eGFR
| Effect | Estimate | |
| Intercept | 12.60 | 0.93 |
| Age (per 1-yr increase) | ||
| HgA1c (per 1% increase) | ||
| Pre-shift eGFR (per 1 ml/min/1.73 m2 increase) | −0.04 | 0.51 |
| Hypertension (ref: no) | 1.06 | 0.84 |
| Pre-shift specific gravity (per 0.1 increase) | 0.17 | 0.90 |
| Pre-shift NGAL | −0.15 | 0.09 |
| Pre-shift pH = 6.0–6.5 (ref: 7.0–7.5) | −2.64 | 0.13 |
| Pre-shift pH = 5.0 (ref: 7.0–7.5) | −0.90 | 0.73 |
| Pre-shift urinary uric acid/creatinine | 2.55 | 0.18 |
| Pre-shift urinary magnesium/creatinine | ||
| Pre-shift urinary sodium/creatinine | −0.001 | 0.81 |
Bold values are statistically significant.
Multivariable Analysis of Post-Shift Biomarkers Associated With Percent Change in Cross-Shift eGFR
| Effect | Estimate | |
| Intercept | 150.25 | <0.01 |
| Age (per 1-yr increase) | ||
| HgA1c (per 1% increase) | −4.4031 | 0.23 |
| Pre-shift eGFR (per 1 mL/min/1.73 m2 increase) | ||
| Hypertension (ref: no) | 6.5354 | 0.22 |
| Average WBGT (per 1 °C increase) | ||
| Osmolality (per 1-unit increase) | −0.2124 | 0.08 |
| Hyperuricemia (ref: no) | ||
| Creatine kinase, 174–870 (ref: ≤174) | 1.6358 | 0.53 |
| Creatine kinase, ≥870 (ref: ≤174) | 1.4272 | 0.74 |
| pH = 6.0–6.5 (ref: 7.0–7.5) | −1.6484 | 0.35 |
| pH = 5.0 (ref: 7.0–7.5) |
Bold values are statistically significant.
WBGT, wet bulb globe temperature.
Multivariable Analysis of Post-Shift Inflammation Associated With Percent Change in Cross-Shift eGFR
| Effect | Estimate | |
| Intercept | 50.55 | 0.04 |
| Age (per 1-yr increase) | ||
| HgA1c (per 1% increase) | ||
| Pre-shift eGFR (per 1 mL/min/1.73 m2 increase) | ||
| Hypertension (ref: no) | 0.54 | 0.92 |
| Post-shift leukocyte esterase (≥70+ /μL) |
Bold values are statistically significant.
eGFR, estimated glomerular filtration rate.